29/01/2018
Similar therapeutic effects were also observed with sobetirome, a well-characterized thyroid-receptor agonist. The results suggest that strategies utilizing lung-targeted TH-therapy should be further studied in patients with fibrotic lung diseases.
Dr. Argyrios Tzouvelekis is a Marie Curie ERS/EU - RESPIRE2 Post-doc Associate at the Biomedical Sciences Research Center Alexander Fleming with Vassilis Aidinis' Research Team.